木瓜直播

Responses to pirtobrutinib observed in patients with previously treated disease

Better survival in one registry study, detriment with class I HLA mismatch in another

Reactions from physician and consumer groups were positive, but drugmakers begged to differ

News, features, and commentary about cancer-related issues

Prices slashed by as much as 79%

Pregnant people and those who are immunocompromised most at risk, agency warns

News, features, and commentary about cancer-related issues

News, features, and commentary about cancer-related issues

New case suggests HIV cure can be achieved independent of stem cell transplant donor CCR5 status

77% of pregnancies resulted in live births

Population-based study suggests reassurance for most, high-risk strategies for some

News, features, and commentary about cancer-related issues

Undetectable MRD rates of 90% or higher, PFS of 7 years or more

All-trans retinoic acid plus arsenic trioxide and idarubicin improved EFS over standard